Relief Cardiovascular
Costa Mesa, US · 3 known investors
Relief Cardiovascular develops transcatheter smart implant systems for volume management in congestive heart failure, including the Relief System, a preload-modulating implant for inferior vena cava flow modulation with autonomous hemodynamic monitoring. It targets heart failure patients with diuretic-resistant congestion whose needs are inadequately met by pharmaceuticals and legacy devices.
Investors · 3
Funding
SEC filings, press & company announcements$12M disclosed across 1 of 2 rounds · 2025
- $12MSeries AJan 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Relief Cardiovascular do?
- Relief Cardiovascular develops transcatheter smart implant systems for volume management in congestive heart failure, including the Relief System, a preload-modulating implant for inferior vena cava flow modulation with autonomous hemodynamic monitoring. It targets heart failure patients with diuretic-resistant congestion whose needs are inadequately met by pharmaceuticals and legacy devices.
- Who are Relief Cardiovascular's investors?
- Relief Cardiovascular's investors include Broadview Ventures, Good Growth Capital, Advent Life Sciences.
- How much funding has Relief Cardiovascular raised?
- Relief Cardiovascular has disclosed $12M raised across 1 of its 2 known rounds.
- Where is Relief Cardiovascular headquartered?
- Relief Cardiovascular is headquartered in Costa Mesa, US.